Category Archives: IN BRIEF:

IN BRIEF: New Multiple Sclerosis Genetic Variants Discovered

IN BRIEF: New Multiple Sclerosis Genetic Variants Discovered

No,  “48 New Multiple Sclerosis Genetic Variants Discovered” does necessarily mean that the likelihood for people to get Multiple Sclerosis (MS) is necessarily higher than previously thought. The study involved  [1] found that with  “new findings, there are now 110 genetic variants associated with MS. Although each of these variants …Read the Rest

IN BRIEF: Phase III Clinical Trials of  Multiple Sclerosis Drug Alemtuzumab Show Progress

IN BRIEF: Phase III Clinical Trials of Multiple Sclerosis Drug Alemtuzumab Show Progress

IN BRIEF: Phase III Clinical Trials of  Multiple Sclerosis Drug Alemtuzumab Show Progress We have noted the great potential of the Multiple Sclerosis Drug Alemtuzumab in a previous posts [1] Note that current research see it prescribed for the Relapsing Remitting (RRMS) form, which is indeed what the clinical trials mentioned …Read the Rest

IN BRIEF: Vitamin K2’s MK-7 Form has More Bio-Availability than MK-4

IN BRIEF: Vitamin K2’s MK-7 Form has More Bio-Availability than MK-4

This is a follow up on our previous post on nutraceuticals and heart disease[1] In a nutshell, vitamin K controls where the calcium is going to take hold. On the bone, where it should, or on endothelial (heart and blood vessels) tissues, where it should not. The consumption of vitamin K2 …Read the Rest

IN BRIEF: A Study Questions The Benefits of Cranberry Juice Against Urinary Tract Infections

IN BRIEF: A Study Questions The Benefits of Cranberry Juice Against Urinary Tract Infections

We have posted several times about the efficacy of cranberry juice against Urinary Tract Infections (UTI) [1] Cranberry juice has been accepted by the nutrition and alternative medicine communities as the first line of defense against UTIs [2,3] UTIs affect particularly women, and people who must  use  a wheelchair for mobility. How …Read the Rest

IN BRIEF: Rosemary Shown To Help Against Depression

IN BRIEF: Rosemary Shown To Help Against Depression

  It is always comforting to hear that a study has shown a culinary herb to be beneficial against a condition. One feels that one can hopefully avoid the cost and side effect of of pharmaceuticals. Plus it brings memories of simpler times when individuals had a better chance at …Read the Rest

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

Teriflunomide (Aubagio, Genzyme/Sanofi) is coming into the MS market [1]. It is an oral drug, nice. Efficacy:  “30% lower than the rate for those taking a placebo,” said Russell Katz, MD,”   What does that mean? Maybe not as clear as just a percent reduction in releases, think compounding. Sagepub …Read the Rest

IN BRIEF: Aromatherapy Validated In Korean Studies

IN BRIEF: Aromatherapy Validated In Korean Studies

Yes, aromatherapy can affect your body in healing ways: An article in Designs For Health [1], brought to my attention by Paul Vitiello,  includes numerous references to serious academic studies on the effect of aromatherapy on human physiology. In particular, a study published by the Korean Society of Nursing Science …Read the Rest

MND BRIEF: Butter flavoring implicated in Alzheimer’s

MND BRIEF: Butter flavoring implicated in Alzheimer’s

From an article in Chemical Research in Toxicology [1], Diacetyl (DA) aggravates beta-amyloid plaques in Alzheimer’s. Problem is besides pop corn butter flavoring, DA is present in many food. Is that News? Yes and no.  We published a post [2] in Dec 2010 discussing another study that shows DA could …Read the Rest

MND BRIEF: Study Shows Multiple Sclerosis Burns Up Vitamin D, But Do Vitamin D supplements fight MS?

MND BRIEF: Study Shows Multiple Sclerosis Burns Up Vitamin D, But Do Vitamin D supplements fight MS?

  A study shows that Multiple Sclerosis (MS) treatment by Interferon-Beta  improves  the ability of the MS patient to produce vitamin D by exposure of their skin to the sun The research was done at the Australian facility  Menzies Research Institute Tasmania Quoting the article [1]: “…In this study, we found …Read the Rest

MND BRIEF: Multiple Sclerosis: Beta interferons (β-IFNs) might not slow disability progression

MND BRIEF: Multiple Sclerosis: Beta interferons (β-IFNs) might not slow disability progression

A new study by the University of British Columbia casts doubt on the benefits of the Interferon treatment against Relapsing-Remitting Multiple Sclerosis Here is the YouTube video from the press release The video tries to mitigate the setback with warm fuzzy statements about future research, but the tone of the …Read the Rest

Page 1 of 3123»

© 2013-2017 Medical News Digest All Rights Reserved